Red Eye, Global Challenge
Narrative review calls for clearer guidance on noninfectious conjunctival hyperemia
Clinical Scorecard: Red Eye, Global Challenge
At a Glance
| Category | Detail |
|---|
| Condition | Noninfectious conjunctival hyperemia |
| Key Mechanisms | Lifestyle and environmental factors including digital eye strain, contact lens wear, cosmetics, smoking, and pollution. |
| Target Population | Individuals experiencing chronic or recurrent redness, particularly those with dry eye disease and ocular allergy. |
| Care Setting | Ophthalmology clinics and general healthcare settings. |
Key Highlights
- Conjunctival hyperemia is a common global ophthalmic presentation.
- Dry eye disease and ocular allergy are leading causes of redness.
- Low-dose brimonidine 0.025% shows promise for redness reduction without tachyphylaxis.
- There is a lack of dedicated management guidelines for noninfectious conjunctival hyperemia.
- Patients increasingly seek redness relief for cosmetic reasons.
Guideline-Based Recommendations
Diagnosis
- Clearer diagnostic pathways are needed to differentiate benign redness from sight-threatening emergencies.
Management
- Consensus recommendations for management of noninfectious conjunctival hyperemia are warranted.
Monitoring & Follow-up
- Long-term real-world data on treatment efficacy and safety is necessary.
Risks
- Caution against surgical 'eye-whitening' procedures due to potential serious complications.
Patient & Prescribing Data
Patients experiencing redness due to noninfectious causes, particularly those with DED and ocular allergy.
Many patients self-treat with over-the-counter drops, but management is often suboptimal.
Clinical Best Practices
- Educate patients on the risks of steroid self-medication.
- Encourage the use of evidence-based pharmacological options like low-dose brimonidine.
- Promote better screening tools for accurate diagnosis.
References
